SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination

Hoffmann, M; Hofmann-Winkler, H; Kruger, N; Kempf, A; Nehlmeier, I; Graichen, L; Arora, P; Sidarovich, A; Moldenhauer, AS; Winkler, MS; Schulz, S; Jack, HM; Stankov, MV; Behrens, GMN; Pohlmann, S

Hoffmann, M; Pohlmann, S (corresponding author), Leibniz Inst Primate Res, Infect Biol Unit, German Primate Ctr, Kellnerweg 4, D-37077 Gottingen, Germany.; Hoffmann, M; Pohlmann, S (corresponding author), Georg August Univ Gottingen, Fac Biol & Psychol, Wilhelmspl 1, D-37073 G6ttingen, Germany.

CELL REPORTS, 2021; 36 (3):

Abstract

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants threatens efforts to contain the coronavirus disease 2019 (COVI......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索